Paper 72 - HARNESSING MUTATIONAL SIGNATURES TO PINPOINT THE DEVELOPMENT OF CHEMORESISTANCE IN METASTATIC AND RELAPSED OSTEOSARCOMA

Author(s)

• 

  Sasha Blay

  PhD Candidate
  The Hospital for Sick Children
  Toronto, Ontario, Canada

  Slides

Co-Author(s)

• ML

  Mehdi Layeghifard, PhD

  The Hospital for Sick Children
  Toronto, Ontario, Canada
• SD

  Scott Davidson, PhD

  The Hospital for Sick Children
  Toronto, Ontario, Canada
• TC

  Taegi Choi, MSc

  The Hospital for Sick Children
  Toronto, Ontario, Canada
• AS

  Astra Schwertschkow, PhD

  The Hospital for Sick Children
  Toronto, Ontario, Canada
• EP

  Elli Papaemmanuil, PhD

  Memorial Sloan Kettering Cancer Center
  New York City, New York, United States
• MC

  Mark Cowley, PhD

  Children's Cancer Institute Australia
  Randwick, New South Wales, Australia
• LS

  Logan Spector, PhD

  University of Minnesota
  Minneapolis, Minnesota, United States
• KO

  Kenan Onel, MD, PhD

  Roswell Park Comprehensive Cancer Center
  Buffalo, New York, United States
• LA

  Ludmil B. Alexandrov, PhD

  University of California San Diego
  San Diego, California, United States
• 

  Jay S. Wunder, MD, MSc, FRCSC

  Surgeon-in-Chief
  Department of Surgery, Sinai Health
  Toronto, Ontario, Canada
• IA

  Irene L. Andrulis, PhD

  Professor, Dept. of Molecular Genetics, University of Toronto Senior Investigator, Lunenfeld-Tanenbaum Research Institute
  Mount Sinai Hospital
  Toronto, Ontario, Canada
• 

  Rebecca A. Gladdy, MD, PhD, FRCSC (she/her/hers)

  Professor of Surgery
  Mount Sinai Hospital
  Toronto, Ontario, Canada
• AV

  Anita Villani, MD

  Division of Hematology/Oncology
  The Hospital for Sick Children
  Toronto, Ontario, Canada
• 

  David Malkin, MD, FRCPC, FRSC, FAACR (he/him/his)

  Division of Hematology/Oncology
  The Hospital for Sick Children
  Toronto, Ontario, Canada
• AS

  Adam Shlien, PhD, FCCMG

  Senior Scientist
  The Hospital for Sick Children
  Toronto, Ontario, Canada